OSE Immunotherapeutics, Nantes, France.
Centre de Recherche en Transplantation et Immunologie (CRTI), UMR 1064, Inserm, Université de Nantes, Nantes, France.
Am J Transplant. 2019 Dec;19(12):3263-3275. doi: 10.1111/ajt.15497. Epub 2019 Jul 8.
Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of immature hematopoietic precursors known to suppress immune responses. Interaction of SIRP alpha (SIRPα), expressed by myeloid cells, with the ubiquitous receptor CD47 is an important immune checkpoint of the innate response regulating macrophages and dendritic cells functions. We previously described that MDSC expressing SIRPα accumulated after transplantation and maintained kidney allograft tolerance. However, the role of the SIRPα/CD47 axis on MDSC function remained unknown. Here, we found that blocking SIRPα or CD47 with monoclonal antibodies (mAbs) induced differentiation of MDSC into myeloid cells overexpressing MHC class II, CD86 costimulatory molecule and increased secretion of macrophage-recruiting chemokines (eg, MCP-1). Using a model of long-term kidney allograft tolerance sustained by MDSC, we observed that administration of blocking anti-SIRPα or CD47 mAbs induced graft dysfunction and rejection. Loss of tolerance came along with significant decrease of MDSC and increase in MCP-1 concentration in the periphery. Graft histological and transcriptomic analyses revealed an inflammatory (M1) macrophagic signature at rejection associated with overexpression of MCP-1 mRNA and protein in the graft. These findings indicate that the SIRPα-CD47 axis regulates the immature phenotype and chemokine secretion of MDSC and contributes to the induction and the active maintenance of peripheral acquired immune tolerance.
髓源抑制性细胞(MDSC)是一种异质性的未成熟造血前体细胞群,已知其具有抑制免疫反应的作用。髓系细胞表达的信号调节蛋白α(SIRPα)与广泛表达的 CD47 受体相互作用是固有免疫反应的一个重要免疫检查点,调节巨噬细胞和树突状细胞的功能。我们之前描述过,移植后表达 SIRPα 的 MDSC 会积聚,并维持肾移植的耐受。然而,SIRPα/CD47 轴对 MDSC 功能的作用仍不清楚。在这里,我们发现用单克隆抗体(mAbs)阻断 SIRPα 或 CD47 可诱导 MDSC 分化为过度表达 MHC Ⅱ类、CD86 共刺激分子的髓系细胞,并增加招募巨噬细胞的趋化因子(如 MCP-1)的分泌。在由 MDSC 维持的长期肾移植耐受模型中,我们观察到阻断抗 SIRPα 或 CD47 mAbs 的给药会导致移植物功能障碍和排斥。耐受的丧失伴随着 MDSC 的显著减少和外周血中 MCP-1 浓度的增加。移植组织学和转录组学分析显示,排斥时出现炎症(M1)巨噬细胞特征,与移植物中 MCP-1 mRNA 和蛋白的过度表达相关。这些发现表明,SIRPα-CD47 轴调节 MDSC 的未成熟表型和趋化因子分泌,并有助于诱导和维持外周获得性免疫耐受。